Alexander Mark Schobel, Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. (AQST), bought 45,871 shares at $0.96 ($44K) on 2022-06-08, disclosed to the SEC on 2022-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AQST | SELL | 2021-02-10 | $236K | — | Filing → |
| AQST | SELL | 2021-02-09 | $265K | — | Filing → |
| AQST | SELL | 2020-05-11 | $200K | — | Filing → |